To determine the efficacy of antiviral agents for recurrent respiratory papillomatosis (RRP) in children and adults.
Study Design
Systematic review to include randomized controlled trials (RCTs), comparative studies (historical and/or nonrandomized), case series, and case reports.
Results
Twenty-six original studies were included (one case-control series, 21 noncomparative trials, four case reports, and no RCTs). Meta-analysis was not possible. The antiviral modalities included acyclovir, ribavirin, intravenous cidofovir, and intralesional cidofovir injections. The strongest evidence was for intralesional cidofovir, with 17 studies including 158 patients. Of these, 90 patients (57%) demonstrated complete resolution, 55 patients (35%) a partial response, and 13 patients (8%) showed no improvement.
Conclusions
Insufficient evidence from controlled trials exists for reliable conclusions, but several series indicate intralesional cidofovir may have some efficacy. A well-designed placebo-controlled, double-blinded, randomized controlled trial is needed.
Significance
This study provides the background for future study design and a comprehensive review of the available evidence.
MorganAHZitschRP.Recurrent respiratory papillomatosis in children: a retrospective study of management and complications.Ear Nose Throat J1986; 65(9):19–28
MenzoSMonachettiATrozziCIdentification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87.J Virol2001; 75(23):11913–9
RabahRLancasterWDThomasRHuman papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease.Pediatr Dev Pathol2001; 4(1):68–72
8.
PouAMRimellFLJordanJAAdult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis.Ann Otol Rhinol Laryngol1995; 104(10 Pt 1):758–62
9.
SilverbergMJThorsenPLindebergHCondyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis.Obstet Gynecol2003; 101(4):645–52
10.
KashimaHKShahFLylesAA comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis.Laryngoscope1992; 102(1):9–13
11.
DerkayCSMalisDJZalzalGA staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis.Laryngoscope1998; 108(6):935–7
MehtaDK.British National Formulary. 46th Edition.British Medical Association and Royal Pharmaceutical Society of Great Britain, London; September 2005
14.
SchraffSDerkayCSBurkeBAmerican Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy.Arch Otolaryngol Head Neck Surg2004; 130(9):1039–42
15.
TascaRAMcCormickMClarkeRW.British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis.Int J Pediatr Otorhinolaryngol2006; 70(7):1183–7
YoungJFry-SmithALungHyde C.volume reduction surgery (LVRS) for chronic obstructive pulmonary disease (COPD) with underlying severe emphysema.Thorax1999; 54(9):779–89
19.
NaimanANAbedipourDAyariSNatural history of adultonset laryngeal papillomatosis following multiple cidofovir injections.Ann Otol Rhinol Laryngol2006; 115(3):175–81
20.
DikkersFG.Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir—a prospective study.Eur Arch Otorhinolaryngol2006; 263(5):440–3
21.
LeeASRosenCA.Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis.J Voice2004; 18(4):551–6
22.
CoJWooP.Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis.Ann Otol Rhinol Laryngol2004; 113(11):859–62
23.
MandellDLArjmandEMKayDJIntralesional cidofovir for pediatric recurrent respiratory papillomatosis.Arch Otolaryngol Head Neck Surg2004; 130(11):1319–23
24.
Peyton ShirleyWWiatrakB.Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children?Int J Pediatr Otorhinolaryngol2004; 68(4):413–8
25.
NaimanANCerusePCoulombeauBIntralesional cidofovir and surgical excision for laryngeal papillomatosis.Laryngoscope2003; 113(12):2174–81
26.
ChhetriDKShapiroNL.A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir.Arch Otolaryngol Head Neck Surg2003; 129(10):1081–5
27.
PranskySMAlbrightJTMagitAE.Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir.Laryngoscope2003; 113(9):1583–7
28.
AkstLMLeeWDiscoloCStepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children.Arch Otolaryngol Head Neck Surg2003; 129(8):841–6
29.
MilczukHA.Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children.Otolaryngol Head Neck Surg2003; 128(6):788–94
30.
El HakimHWaddellAN, Crysdale WS. Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir. J Otolaryngol2002; 31(6):333–5
31.
BielamowiczSVillagomezVStagerSVIntralesional cidofovir therapy for laryngeal papilloma in an adult cohort.Laryngoscope2002; 112(4):696–9
32.
ChhetriDKBluminJHShapiroNLOffice-based treatment of laryngeal papillomatosis with percutaneous injection of cidofovir.Otolaryngol Head Neck Surg2002; 126(6):642–8
33.
ArmbrusterCKreuzerAVorbachHSuccessful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon a-2b.Eur Respir J2001; 17(4):830–1
34.
BalauffASiraJPearmanKSuccessful ribavirin therapy for life-threatening laryngeal papillomatosis post liver transplantation.Pediatr Transplant2001; 5(2):142–4
35.
Van ValckenborghIWellensWDe BoeckKSystemic cidofovir in papillomatosis.Clin Infect Dis2001; 32(3):E62–4
36.
PranskySMBrewsterDFMagitAEClinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis.Arch Otolaryngol Head Neck Surg2000; 126(10):1239–43
37.
WilsonWRHashemiyoonRHawrychA.Intralesional cidofovir for recurrent laryngeal papillomas: preliminary report.Ear Nose Throat J2000; 79(4):236–8.240
38.
DanceyDRChamberlainDWKrajdenMSuccessful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature.Chest2000; 118(4):1210–4
39.
PranskySMMagitAEKearnsDBIntralesional cidofovir for recurrent respiratory papillomatosis in children.Arch Otolaryngol Head Neck Surg1999; 125(10):1143–8
40.
SnoeckRWellensWDesloovereCTreatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].J Med Virol1998; 54(3):219–25
41.
KirogluMCetikFSoyluLAcyclovir in the treatment of recurrent respiratory papillomatosis: a preliminary report.Am J Otolaryngol1994; 15(3):212–4
42.
EndresDRBaumanNMBurkeDAcyclovir in the treatment of recurrent respiratory papillomatosis. A pilot study.Ann Otol Rhinol Laryngol1994; 103(4 Pt 1):301–5
43.
McGlennenRCAdamsGLLewisCMFarasAJOstrow RS. Pilottrial of ribavirin for the treatment of laryngeal papillomatosis.Head Neck1993; 15(6):504–12; discussion 512-3
44.
Lopez AguadoDPerez PineroBBetancorLAcyclovir in the treatment of laryngeal papillomatosis.Int J Pediatr Otorhinolaryngol1991; 21(3):269–74
45.
OstrowRSForslundKMMcGlennenRCRibavirin mitigates wart growth in rabbits at early stages of infection with cottontail rabbit papillomavirus.Antiviral Res1992; 17(2):99–113
46.
WachsmanMPettyBGCundyKCPharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects.Antiviral Res1996; 29(2-3):153–61
47.
CundyKCLynchGLeeWA.Bioavailability and metabolism of cidofovir following topical administration to rabbits.Antiviral Res1997; 35(2):113–22
48.
NaimanANRogerGGagnieuMCCidofovir plasma assays after local injection in respiratory papillomatosis.Laryngoscope2004; 114(7):1151–6
49.
DerkayC.Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks.Int J Pediatr Otorhinolaryngol2005; 69(11):1465–7
50.
ArmstrongLRDerkayCSReevesWC.Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force.Arch Otolaryngol Head Neck Surg1999; 125(7):743–8
